Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 161 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1601 6.3 months Malignant Pleural Mesothelioma 5 Biologic therapy
University of California Irvine School of Medicine United States 2/2015
Treatment Details: Patients: This phase 2 study involved 59 malignant pleural mesothelioma patients who had received prior treatment. The median patient age was 67 years and 76% were male. Treatment: Pat
 
1602 6.2 months Malignant pleural mesothelioma 4 Chemotherapy
Humanitas Clinical and Research Center Italy 11/2013
Treatment Details: Patients: This study involved 59 malignant pleural mesothelioma patients who had been previously treated with pemetrexed. The median patient age was 69 years and 64.4% were male. Treatm
 
1603 6.2 months Metastatic urothelial carcinoma 4 Chemotherapy
Philipps University Marburg Germany 12/2013
Treatment Details: Patients: This study involved 21 advanced or metastatic urothelial cancer patients who had received prior platinum-based chemotherapy. The median patient age was 63.0 years and 90.5% were
 
1604 6.2 months T cell lymphoma 5 Chemotherapy
Centre Hospitalier Universitaire France 10/2012
Treatment Details: Patients: This phase 2 study involved 60 T cell lymphoma patients whose cancer had progressed after prior chemotherapy. The median patient age was 66 years and 38 patients were male. T
 
1605 6.2 months Advanced hepatocellular carcinoma 4 Chemotherapy
NYU School of Medicine United States 10/2010
Treatment Details: Patients: This study involved 15 patients with advanced hepatocellular carcinoma with a median patient age of 60 years and 93.3% were male. Treatment: Patients were treated with the che
 
1606 6.2 months Newly diagnosed GBM 3 Biologic therapy
Hygeia Hospital Greece 10/2009
Treatment Details: Patients: This phase 2 study involved 20 patients with glioblastoma multiforme. Three of these patients had a mix of glioblastoma and astrocytoma. There were 14 men and six women in this
 
1607 6.2 months Advanced or metastatic NSCLC 5 Chemotherapy
University Hospital Groningen Netherlands 1/2005
Treatment Details: Patients: This Phase II study involved 108 patients. The patients were divided into two groups. 52 patients were assigned to Group B. The median age of Group B was 58, and twenty were wom
 
1608 6.2 months advanced melanoma 4 Immunotherapy
University of Virginia United States 11/2003
Treatment Details: Patients: This Phase II study involved 26 patients with advanced melanoma. Patients were divided into two groups of 13 patients each - Group A and Group B. There were 6 men and 7 women in
 
1609 6.1 months metastatic breast cancer 4 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 3/2005
Treatment Details: Patients: This Phase II study involved 16 women with metastatic breast cancer. The median age was 55 years. All but one received chemotherapy before the study, and all had at least one me
 
1610 6.1 months Advanced hepatocellular carcinoma 5 Biologic therapy
Université Paris Est Créteil France 3/2012
Treatment Details: Patients: This phase II study involved 25 advanced hepatocellular carcinoma patients who were not previously treated with any systemic therapy. The median patient age was 60.2 years and 23
 
Page 161 of 187  | Previous Page  | Next Page